Long-term results from the phase 2 OVARIO trial (NCT03326193) highlight the effectiveness of niraparib plus bevacizumab as maintenance therapy in patients with advanced ovarian cancer.

The Board of Directors of The AES Corporation (NYSE: AES) declared a quarterly common stock dividend of $0.17595 per ...

The Board of Directors of The AES Corporation (NYSE: AES) declared a quarterly common stock dividend of $0.17595 per share ...

A Wall Street maxim states, “Twenty percent of investors who want to make money are in stocks, while the other 80 percent who ...

AES Corp is not a stock that makes headlines for significant price fluctuations, but investors were startled this week when it increased almost 20% in just one session.

AES Corp, which provides renewable power to tech giants such as Microsoft Corp, is exploring options including a potential ...

AES Corp. closed 38.87% below its 52-week high of $20.30, which the company reached on October 1st.

AES Corporation’s core value still hinges on major data center power contracts and steady cash flows. Click here to find out ...

The minutes for the mid-June meeting showed that most Fed officials said they expect rate cuts will be appropriate later this ...

Wall Street indexes closed higher on Wednesday, led by the tech-heavy Nasdaq as Nvidia briefly reached a $4 trillion ...

AES shares are trading higher after Bloomberg reported that the company is exploring options amid takeover interest.

The S&P 500 climbed 0.61% on Wednesday (July 9), driven by gains in tech stocks as Nvidia hit a historic milestone and ...